Premature menopause and unexplained infertility are associated with ovarian
antibodies, a marker of ovarian autoimmunity. In premature menopause, FSH
is also elevated while in unexplained infertility FSH concentrations are of
ten normal. The relationship of ovarian antibodies and FSH and inhibin B, a
s markers of follicle function, was investigated in unexplained infertility
. Ovarian antibodies were determined by immunoassay in comparison to normal
controls (n = 12); 51.9% were positive at two SD (P < 0.05) and 38.5% were
positive at three SD above the control mean (P < 0.01). In this study thre
e SD above the control mean was considered positive. In unexplained inferti
lity, three out of 10 (30%) had elevated day 3 FSH (>10 mIU/ml) and ovarian
antibodies, while 17/42 (40%) had normal FSH (<10 mIU/ml) and ovarian anti
bodies. In women with normal FSH, two out of seven (29%) had low inhibin B
concentrations (<33 pg/ml) and ovarian antibodies, and 15/35 (43%) had norm
al inhibin B concentrations (>33 pg/ml) and ovarian antibodies. Similarly,
when women with and without ovarian antibodies were compared there was no d
ifference in mean FSH or mean inhibin B concentrations. Thus, unlike other
endocrine autoimmune disorders, hormone concentrations are not predictors o
f potential ovarian autoimmunity. This suggests that in unexplained inferti
lity ovarian antibodies are an independent marker of potential ovarian fail
ure, and may precede changes in regulatory hormones.